These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38230266)

  • 1. Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes.
    Kanai R; Kinoshita S; Kanbe I; Sameda M; Yamaoka S; Horikawa O; Watanabe Y; Tatsuno I; Shirai K; Oshiro T; Saiki A
    Obes Pillars; 2024 Mar; 9():100098. PubMed ID: 38230266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Antrum Size on Weight Loss, Glucagon-Like Peptide-1 (GLP-1) Levels, and Glycemic Control Following Laparoscopic Sleeve Gastrectomy in Adolescents with Obesity and Type 2 Diabetes.
    Shehata MA; Elhaddad A; El-Attar AA; Shehata SM
    Obes Surg; 2021 Oct; 31(10):4376-4385. PubMed ID: 34355337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study).
    Nomoto H; Oba-Yamamoto C; Takahashi Y; Takeuchi J; Nagai S; Yokoyama H; Taneda S; Kurihara Y; Aoki S; Kameda H; Cho KY; Nakamura A; Atsumi T; Miyoshi H
    Diabetes Ther; 2021 Mar; 12(3):955-964. PubMed ID: 33491111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk factor analysis on body mass rebound after laparoscopic sleeve gastrectomy and establishment of a nomogram prediction model].
    Zhao J; Jiao YW; Qian J; Qian ZF; Yang HJ; Tang LM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Oct; 25(10):913-920. PubMed ID: 36245117
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgery for weight loss in adults.
    Colquitt JL; Pickett K; Loveman E; Frampton GK
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003641. PubMed ID: 25105982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving Basal Insulin.
    Witkowski M; Wilkinson L; Webb N; Weids A; Glah D; Vrazic H
    Diabetes Ther; 2018 Jun; 9(3):1233-1251. PubMed ID: 29713961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Conventional Medical Therapy or Laparoscopic Sleeve Gastrectomy on Urinary Albumin in Japanese Subjects with Severe Obesity: An Observational Study.
    Watanabe Y; Yamaguchi T; Yamaoka S; Abe K; Onda H; Nakamura S; Tanaka S; Oshiro T; Ohira M; Nagayama D; Shimizu N; Tatsuno I; Saiki A
    Obes Facts; 2021; 14(6):613-621. PubMed ID: 34649255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.
    Witkowski M; Wilkinson L; Webb N; Weids A; Glah D; Vrazic H
    Diabetes Ther; 2018 Jun; 9(3):1149-1167. PubMed ID: 29675798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of laparoscopic sleeve gastrectomy on type 2 diabetes remission outcomes in patients with body mass index between 25 kg/m 2 and 32.5 kg/m 2.
    Ma S; Wang L; Chen J; Zhao Y; Jiang T
    Asian J Surg; 2022 Jan; 45(1):315-319. PubMed ID: 34246535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of Once-Weekly GLP-1 Receptor Agonist Semaglutide on Glycemic Control in Subjects with Type 2 Diabetes Mellitus: Switching from the Same Class Dulaglutide in a Retrospective Observation Study.
    Kimura T; Kubo M; Takahashi K; Wamata R; Iwamoto Y; Iwamoto H; Katakura Y; Sanada J; Fushimi Y; Shimoda M; Tatsumi F; Nakanishi S; Mune T; Kaku K; Kaneto H
    J Diabetes Res; 2024; 2024():5880589. PubMed ID: 38223524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Patient-Reported Satisfaction and Clinical Efficacy of Once-Weekly Semaglutide in Patients with Type 2 Diabetes: An Ambispective Study.
    Al Hayek AA; Al Dawish MA
    Adv Ther; 2022 Apr; 39(4):1582-1595. PubMed ID: 35119622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic Sleeve Gastrectomy versus Lifestyle Modification in Class I Obesity in Pakistani Population: A Prospective Cohort Study.
    Amin A; Siddiq G; Haider MI; Khalid Choudry U; Nazir I
    Cureus; 2019 Jun; 11(6):e5031. PubMed ID: 31501724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center.
    Enochs P; Bull J; Surve A; Cottam D; Bovard S; Bruce J; Tyner M; Pilati D; Cottam S
    Surg Obes Relat Dis; 2020 Jan; 16(1):24-33. PubMed ID: 31753795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Relapse of Type 2 Diabetes Mellitus after Laparoscopic Sleeve Gastrectomy in Japanese Subjects: A Subgroup Analysis of J-SMART Study.
    Watanabe Y; Yamaguchi T; Nagayama D; Tanaka S; Sasaki A; Naitoh T; Matsubara H; Yokote K; Okazumi S; Ugi S; Yamamoto H; Ohta M; Ishigaki Y; Kasama K; Seki Y; Tsujino M; Shirai K; Miyazaki Y; Masaki T; Saiki A; Tatsuno I
    Obes Facts; 2023; 16(2):119-130. PubMed ID: 36750042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic.
    Hansen KB; Svendstrup M; Lund A; Knop FK; Vilsbøll T; Vestergaard H
    Diabet Med; 2021 Oct; 38(10):e14655. PubMed ID: 34291491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy on fasting gastrointestinal and pancreatic peptide hormones: A prospective nonrandomized trial.
    Yang J; Gao Z; Williams DB; Wang C; Lee S; Zhou X; Qiu P
    Surg Obes Relat Dis; 2018 Oct; 14(10):1521-1529. PubMed ID: 30449509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Japanese Patients with BMI < 35 kg/m
    Seki Y; Kasama K; Yasuda K; Yokoyama R; Porciuncula JP; Kurokawa Y
    Obes Surg; 2018 Aug; 28(8):2429-2438. PubMed ID: 29502278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.
    Malkin SJP; Russel-Szymczyk M; Psota M; Hlavinkova L; Hunt B
    Adv Ther; 2019 Aug; 36(8):2034-2051. PubMed ID: 31168765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy with 12+ months of adjuvant multidisciplinary support.
    Carr P; Keighley T; Petocz P; Blumfield M; Rich GG; Cohen F; Soni A; Maimone IR; Fayet-Moore F; Isenring E; Marshall S
    BMC Prim Care; 2022 Feb; 23(1):26. PubMed ID: 35123409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria.
    Di Loreto C; Minarelli V; Nasini G; Norgiolini R; Del Sindaco P
    Diabetes Ther; 2022 Mar; 13(3):551-567. PubMed ID: 35230650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.